Enter assignee name

CIPO Patents = 2

Forward Citations = 54

Loading Chart...

6 inventors (with patents filed for the assignee):

Tony Cruz (5 out of 5 patents)

Aleksandra Pastrak (5 out of 5 patents)

John J Nestor (2 out of 13 patents)

4. Eva Anne Turley (1 out of 11 patents)

5. David C Schriemer (0 patent)

6. Ole Hindsgaul (0 patent)

7 patents: Sort by Forward Citations

1. 7595294 - Vasoactive intestinal polypeptide pharmaceuticals (2009-09-29),

2. 7566691 - Vasoactive intestinal polypeptide pharmaceuticals (2009-07-28),

3. 7026355 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2006-04-11),

4. 6911429 - Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans (2005-06-28),

5. 6908611 - Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases (2005-06-21),

6. 6894033 - Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases (2005-05-17),

7. 6797727 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2004-09-28),

Transition Therapeutics is a biopharmaceutical company focused on the research and development of innovative therapies for the treatment of diseases with high unmet medical needs. Their approach centers on identifying promising compounds and advancing them through various stages of clinical development to bring important medications to market that can improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#185 in Toronto

#2,026 in Canada

Toronto, Canada

Transition Therapeutics, Inc.